Jin Medical International Ltd. (ZJYL) Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 2021 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Jin Medical International Ltd. quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect history and growth rate from 2021 to 2023.
  • Jin Medical International Ltd. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending September 30, 2023 was $2.14M, a 90.7% increase year-over-year.
  • Jin Medical International Ltd. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the twelve months ending September 30, 2023 was $2.14M.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Trailing 12 Months (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly Data (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $2.14M +$1.02M +90.7% Oct 1, 2022 Sep 30, 2023 20-F 2024-04-26
Q3 2022 $1.12M -$888K -44.2% Oct 1, 2021 Sep 30, 2022 20-F 2024-04-26
Q3 2021 $2.01M Oct 1, 2020 Sep 30, 2021 20-F 2024-04-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.